|
PIK3C2A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.74225087082414E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.10049999405504E-09 |
| Normal-vs-Stage2 |
1.90104999999718E-05 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
5.385000E-01 |
| Stage1-vs-Stage3 |
2.767900E-04 |
| Stage1-vs-Stage4 |
3.22799999952217E-07 |
| Stage2-vs-Stage3 |
1.295980E-01 |
| Stage2-vs-Stage4 |
2.389800E-02 |
| Stage3-vs-Stage4 |
2.225400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.80944148553408E-12 |
| Normal-vs-AfricanAmerican |
1.59320334702784E-11 |
| Normal-vs-Asian |
8.806000E-02 |
| Caucasian-vs-AfricanAmerican |
2.437200E-01 |
| Caucasian-vs-Asian |
3.004600E-01 |
| AfricanAmerican-vs-Asian |
1.140380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.48689957516035E-14 |
| Normal-vs-Female |
8.73440209048226E-11 |
| Male-vs-Female |
1.852590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.24869999959832E-07 |
| Normal-vs-Age(41-60Yrs) |
1.66370028864549E-10 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
9.07660002713584E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.076600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.268800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.345200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.756300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.686000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.219400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.215440E-01 |
| Normal-vs-Grade 2 |
6.00120000360249E-08 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
3.255200E-01 |
| Grade 1-vs-Grade 3 |
7.614300E-04 |
| Grade 1-vs-Grade 4 |
1.50944999999236E-05 |
| Grade 2-vs-Grade 3 |
2.27949999999089E-05 |
| Grade 2-vs-Grade 4 |
1.54199997215443E-09 |
| Grade 3-vs-Grade 4 |
2.297200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.41429999997744E-07 |
| Normal-vs-ccB subtype |
1.63213886850144E-12 |
| ccA subtype-vs-ccB subtype |
5.93829999999684E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.45836684342748E-12 |
| Normal-vs-N1 |
1.40699999984228E-07 |
| N0-vs-N1 |
1.809820E-01 |
|
|
